The First International Symposium on Kallikreins

Artikel in diesem Heft

1. The First International Symposium on Kallikreins
2. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins
3. The kallikrein world: an update on the human tissue kallikreins
4. Cellular distribution of human tissue kallikreins: immunohistochemical localization
5. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
6. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more
7. Recombinant kallikrein expression: site-specific integration for hK6 production in human cells
8. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
9. The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition
10. Human kallikrein 10, a predictive marker for breast cancer
11. Activation and enzymatic characterization of recombinant human kallikrein 8
12. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies
13. The human kallikrein 10 promoter contains a functional retinoid response element
14. Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins
15. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum
16. A sensitive proximity ligation assay for active PSA
17. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer
18. Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues
19. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy
20. The epigenetic basis for the aberrant expression of kallikreins in human cancers
21. Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
22. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
23. Inhibition profiles of human tissue kallikreins by serine protease inhibitors
24. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)